China NMPA Product Recall - Ventilator

On June 16, 2022, the National Medical Products Administration (NMPA) publicly announced a significant voluntary Class I recall initiated by Respironics California, Inc. This critical action targets a specific model and batch of the company's V60 ventilator. Philips (China) Investment Co., Ltd. initially identified and reported that the V60 ventilator may contain internal circuitry issues, posing a potential risk of causing breathing problems for users in certain low-probability situations. The designation of this as a Class I recall is highly significant; it indicates that regulatory authorities have determined there is a reasonable probability that the use of or exposure to the affected product could lead to serious adverse health consequences or even death. Consequently, Respironics California, Inc. is undertaking this recall as a crucial measure to mitigate potential risks and uphold patient safety standards. All relevant details concerning the affected ventilator models, their specifications, and specific batch numbers are meticulously documented in the accompanying "Medical Device Recall Event Report Form." This proactive response by the manufacturer, under the NMPA's stringent regulatory framework, demonstrates a commitment to addressing product safety issues promptly and responsibly to protect public health.